Maura Gillison L MD, PhD

Maura Gillison L MD, PhD
ProfessorCollege of Medicinegillison.3@osu.edu
690 Tzagournis Med Res Facility 420 W 12th Avenue Columbus Ohio 43210
Phone:614-247-4589Fax: (614) 688-4245
  • Cancer Control

General Research Interest

Head and neck cancer, human papillomavirus, infectious-disease tumor associations

Research Description

The principal focus of the Gillison laboratory is to investigate the role of human papillomavirus infection in head and neck malignancies, from cohort studies of oral HPV infection to genetic indicators of response to chemoradiotherapy.

Transinstitutional Work

The Gillison laboratory has several ongoing collaborations with the Centers for Disease Control, USA, the National Cancer Institute, USA, and the International Agency for Research on Cancer. Dr. Gillison is also a member of the head and neck steering committees of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology Group.

Current Publications

  • Chaturvedi AK, Graubard BI, Pickard RK, Xiao W, Gillison Maura LHigh-Risk Oral Human Papillomavirus Load in the US Population, National Health and Nutrition Examination Survey 2009-2010.J Infect Dis 210 441-7 8/1/2014
  • Harari PM, Harris J, Kies MS, Myers JN, Jordan RC, Gillison ML, Foote RL, Machtay M, Rotman M, Khuntia D, Straube W, Zhang Q, Ang KPostoperative Chemoradiotherapy and Cetuximab for High-Risk Squamous Cell Carcinoma of the Head and Neck: Radiation Therapy Oncology Group RTOG-0234.J Clin Oncol in press 7/7/2014
  • Fakhry C, Agrawal N, Califano J, Messing B, Liu J, Saunders J, Ha P, Coquia S, Hamper U, Gillison M, Blanco RThe use of ultrasound in the search for the primary site of unknown primary head and neck squamous cell cancers.Oral Oncol 50 640-5 7/1/2014
  • Fakhry C, Zhang Q, Nguyen-Tan PF, Rosenthal D, El-Naggar A, Garden AS, Soulieres D, Trotti A, Avizonis V, Ridge JA, Harris J, Le QT, Gillison MauraHuman Papillomavirus and Overall Survival After Progression of Oropharyngeal Squamous Cell Carcinoma.J Clin Oncol in press 6/23/2014
  • Steinau M, Hariri S, Gillison ML, Broutian TR, Dunne EF, Tong ZY, Markowitz LE, Unger ERPrevalence of cervical and oral human papillomavirus infections among US women.J Infect Dis 209 1739-43 6/1/2014
  • D'Souza G, Gross ND, Pai SI, Haddad R, Anderson KS, Rajan S, Gerber J, Gillison ML, Posner MROral Human Papillomavirus (HPV) Infection in HPV-Positive Patients With Oropharyngeal Cancer and Their Partners.J Clin Oncol in press 4/28/2014
  • Adams AK, Hallenbeck GE, Casper KA, Patil YJ, Wilson KM, Kimple RJ, Lambert PF, Witte DP, Xiao W, Gillison ML, Wikenheiser-Brokamp KA, Wise-Draper TM, Wells SIDEK promotes HPV-positive and -negative head and neck cancer cell proliferation.Oncogene in press 1 3/10/2014
  • Gillison ML, Castellsagué X, Chaturvedi A, Goodman MT, Snijders P, Tommasino M, Arbyn M, Franceschi SEurogin Roadmap: comparative epidemiology of HPV infection and associated cancers of the head and neck and cervix.Int J Cancer 134 497-507 2/1/2014
  • Akagi K, Li J, Broutian TR, Padilla-Nash H, Xiao W, Jiang B, Rocco JW, Teknos TN, Kumar B, Wangsa D, He D, Ried T, Symer DE, Gillison MLGenome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability.Genome Res 24 185-99 2/1/2014
  • Blanco RG, Califano J, Messing B, Richmon J, Liu J, Quon H, Neuner G, Saunders J, Ha PK, Sheth S, Gillison M, Fakhry CTranscervical ultrasonography is feasible to visualize and evaluate base of tongue cancers.PLoS One 9 e87565 1/1/2014
  • Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S, authors of ICO Monograph Comprehensive Control of HPV Infections and Related Diseases Vaccine Volume 30, Supplement 5, 2012Comprehensive control of human papillomavirus infections and related diseases.Vaccine 31 Suppl 7 H1-31 12/31/2013
  • Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S, ICO Monograph 'Comprehensive Control of HPV Infections and Related Diseases' Vaccine Volume 30, Supplement 5, 2012, Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman MComprehensive control of human papillomavirus infections and related diseases.Vaccine 31 Suppl 6 G1-31 12/30/2013
  • Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S, authors of the ICO Monograph ‘Comprehensive Control of HPV Infections and Related Diseases’ Vaccine Volume 30, Supplement 5, 2012, Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak MComprehensive control of human papillomavirus infections and related diseases.Vaccine 31 Suppl 5 F1-31 12/29/2013
  • Franceschi S, Rosenberg PS, Bray F, Gillison ML, Chaturvedi AK, Anderson WF, Lortet-Tieulent J, Curado MP, Ferlay JWorldwide trends in incidence rates for oral cavity and oropharyngeal cancers.J Clin Oncol 31 4550-9 12/20/2013
  • Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S, Authors of the ICO Monograph ‘Comprehensive Control of HPV Infections and Related Diseases’ Vaccine Volume 30, Supplement 5, 2012Comprehensive control of human papillomavirus infections and related diseases.Vaccine 31 Suppl 8 I1-31 11/22/2013
  • Perez-Ordoñez B, Irish JC, Yu ES, Gillison MLHuman papillomavirus-16 associated adenocarcinoma NOS of base of tongue.Head Neck Pathol 7 268-73 9/1/2013
  • Haddad RI, Haughey BH, Hicks WL, Hitchcock YJ, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pinto HA, Ridge JA, Samant S, Schuller DE, Shah JP, Spencer S, Weber RS, Wolf GT, Worden F, Yom SS, McMillian NR, Hughes M, National Comprehensive Cancer Network, Pfister DG, Ang KK, Brizel DM, Burtness BA, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison MLHead and neck cancers, version 2.2013. Featured updates to the NCCN guidelines.J Natl Compr Canc Netw 11 917-23 8/1/2013
  • Beachler DC, D'Souza G, Sugar EA, Xiao W, Gillison MLNatural history of anal vs oral HPV infection in HIV-infected men and women.J Infect Dis 208 330-9 7/15/2013
  • Lingen MW, Xiao W, Schmitt A, Jiang B, Pickard R, Kreinbrink P, Perez-Ordonez B, Jordan RC, Gillison MLLow etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas.Oral Oncol 49 1-8 1/1/2013
  • Gillison ML, Alemany L, Snijders PJ, Chaturvedi A, Steinberg BM, Schwartz S, Castellsagué XHuman papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis.Vaccine 30 Suppl 5 F34-54 11/20/2012

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 300 W. 10th Ave. Columbus, OH 43210 Phone: 1-800-293-5066 | Email: jamesline@osumc.edu